System and Method for Controlling Ventricular Pacing During AF Based on Underlying Ventricular Rates Using an Implantable Medical Device
AssigneePacesetter, Inc.
InventorsPeter Boileau, Michael E. Benser
Life of this patent
Estimating the term…
Loading patent…
AssigneePacesetter, Inc.
InventorsPeter Boileau, Michael E. Benser
Estimating the term…
Techniques are provided for controlling ventricular pacing during an episode of atrial fibrillation (AF) for use by a pacemaker, implantable cardioverter-defibrillator (ICD) or other implantable medical device. In one example, upon detection of AF, the underlying intrinsic ventricular rate of the patient is determined prior to delivering any ventricular pacing. Then, a ventricular pacing procedure—such as dynamic ventricular overdrive (DVO) pacing—is activated to reduce ventricular rate variability to mitigate the adverse effects of AF. The ventricular pacing procedure employed during AF is controlled based on a maximum ventricular rate set relative to the underlying intrinsic ventricular rate so as to keep an overall ventricular rate below the maximum rate.
A method for use by an implantable medical device equipped to selectively deliver pacing therapy to the ventricles during atrial fibrillation (AF), comprising:
A system for use with an implantable medical device equipped to selectively deliver pacing therapy to the ventricles, comprising:
A system for use with an implantable medical device equipped to selectively deliver pacing therapy to the ventricles during an episode of atrial fibrillation (AF), comprising:
Dependencies are inferred from the claim text.